Published in DNA Res on April 30, 1996
Use of 16S rRNA, 23S rRNA, and gyrB gene sequence analysis to determine phylogenetic relationships of Bacillus cereus group microorganisms. J Clin Microbiol (2004) 1.18
Fundamentals of sequencing of difficult templates--an overview. J Biomol Tech (2006) 1.15
A DNA cycle sequencing reaction that minimizes compressions on automated fluorescent sequencers. Nucleic Acids Res (1997) 0.93
Molecular evaluation of human ubiquilin 2 gene PXX domain in familial frontotemporal dementia patients. J Neurol (2012) 0.75
Confirmation of translatability and functionality certifies the dual endothelin1/VEGFsp receptor (DEspR) protein. BMC Mol Biol (2016) 0.75
The transcriptional landscape of the mammalian genome. Science (2005) 37.63
Association of structural polymorphisms in the human period3 gene with delayed sleep phase syndrome. EMBO Rep (2001) 2.43
Dog and rat pancreatic phospholipases A2: complete amino acid sequences deduced from complementary DNAs. J Biochem (1986) 2.36
Prediction of the coding sequences of unidentified human genes. XI. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro. DNA Res (1998) 2.15
Direct observation of DNA rotation during transcription by Escherichia coli RNA polymerase. Nature (2001) 2.06
Prediction of the coding sequences of unidentified human genes. XVII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro. DNA Res (2000) 2.06
Construction and characterization of human brain cDNA libraries suitable for analysis of cDNA clones encoding relatively large proteins. DNA Res (1997) 1.92
Prediction of the coding sequences of unidentified human genes. VII. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro. DNA Res (1997) 1.87
Multitissue circadian expression of rat period homolog (rPer2) mRNA is governed by the mammalian circadian clock, the suprachiasmatic nucleus in the brain. J Biol Chem (1998) 1.86
Prediction of the coding sequences of unidentified human genes. XIV. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro. DNA Res (1999) 1.82
Prediction of the coding sequences of unidentified human genes. IX. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro. DNA Res (1998) 1.74
HUGE: a database for human large proteins identified in the Kazusa cDNA sequencing project. Nucleic Acids Res (2000) 1.69
Prediction of the coding sequences of unidentified human genes. XIII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro. DNA Res (1999) 1.60
Prediction of the coding sequences of unidentified human genes. XX. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro. DNA Res (2001) 1.54
Prediction of the coding sequences of unidentified human genes. XV. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro. DNA Res (1999) 1.47
Gastrocolic fistula originating from transverse colon cancer: report of a case and review of the Japanese literature. Surg Today (1994) 1.41
Prediction of the coding sequences of unidentified human genes. X. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro. DNA Res (1998) 1.41
Prediction of the coding sequences of unidentified human genes. XII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro. DNA Res (1998) 1.39
Prediction of the coding sequences of unidentified human genes. XVI. The complete sequences of 150 new cDNA clones from brain which code for large proteins in vitro. DNA Res (2000) 1.39
Identification of high-molecular-weight proteins with multiple EGF-like motifs by motif-trap screening. Genomics (1998) 1.34
Prediction of the coding sequences of unidentified human genes. XIX. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro. DNA Res (2000) 1.33
Vascular smooth muscle cell-derived, Gla-containing growth-potentiating factor for Ca(2+)-mobilizing growth factors. J Biol Chem (1995) 1.33
Towards a proteome project of cyanobacterium Synechocystis sp. strain PCC6803: linking 130 protein spots with their respective genes. Electrophoresis (1997) 1.33
Prediction of the coding sequences of unidentified human genes. VIII. 78 new cDNA clones from brain which code for large proteins in vitro. DNA Res (1997) 1.28
HUGE: a database for human large proteins identified by Kazusa cDNA sequencing project. Nucleic Acids Res (1999) 1.27
Prediction of the coding sequences of unidentified human genes. XVIII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro. DNA Res (2000) 1.21
Molecular cloning of pancreatic group I phospholipase A2 receptor. J Biol Chem (1994) 1.15
Glucocorticoids suppress group II phospholipase A2 production by blocking mRNA synthesis and post-transcriptional expression. J Biol Chem (1990) 1.15
Gene identification in 1.6-Mb region of the Down syndrome region on chromosome 21. Genome Res (1997) 1.10
Characterization of a new beta-spectrin gene which is predominantly expressed in brain. Brain Res Mol Brain Res (1998) 1.10
Group II phospholipase A2 mRNA synthesis is stimulated by two distinct mechanisms in rat vascular smooth muscle cells. FEBS Lett (1990) 1.08
Sequence features surrounding the translation initiation sites assigned on the genome sequence of Synechocystis sp. strain PCC6803 by amino-terminal protein sequencing. DNA Res (1996) 1.07
Cyano2Dbase updated: linkage of 234 protein spots to corresponding genes through N-terminal microsequencing. Electrophoresis (1999) 1.06
Prediction of the coding sequences of unidentified human genes. XXII. The complete sequences of 50 new cDNA clones which code for large proteins. DNA Res (2001) 1.04
Type II brain 4.1 (4.1B/KIAA0987), a member of the protein 4.1 family, is localized to neuronal paranodes. Brain Res Mol Brain Res (2000) 1.04
Unique activation status of peripheral blood mononuclear cells at acute phase of Kawasaki disease. Clin Exp Immunol (2009) 1.03
Preliminary report: effect of adrenal androgen and estrogen on bone maturation and bone mineral density. Metabolism (2001) 1.02
Single molecular assay of individual ATP turnover by a myosin-GFP fusion protein expressed in vitro. FEBS Lett (1997) 1.01
Characterization of cDNA clones selected by the GeneMark analysis from size-fractionated cDNA libraries from human brain. DNA Res (1999) 1.01
Identification of three novel non-classical cadherin genes through comprehensive analysis of large cDNAs. Brain Res Mol Brain Res (2001) 0.99
Characterization of cDNA clones in size-fractionated cDNA libraries from human brain. DNA Res (1997) 0.97
Prediction of the coding sequences of unidentified human genes. XXI. The complete sequences of 60 new cDNA clones from brain which code for large proteins. DNA Res (2001) 0.97
cDNA cloning and sequence determination of rat membrane-associated phospholipase A2. Biochem Biophys Res Commun (1989) 0.96
Molecular characterization of a new member of the protein 4.1 family (brain 4.1) in rat brain. Brain Res Mol Brain Res (1999) 0.95
Effects of brain-derived neurotrophic factor on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in monkeys. Neurosurgery (1995) 0.93
A DNA cycle sequencing reaction that minimizes compressions on automated fluorescent sequencers. Nucleic Acids Res (1997) 0.93
Distinctive four promoters collectively direct expression of brain-derived neurotrophic factor gene. Brain Res Mol Brain Res (1994) 0.92
Characterization of a human homolog (BACH1) of the mouse Bach1 gene encoding a BTB-basic leucine zipper transcription factor and its mapping to chromosome 21q22.1. Genomics (1998) 0.91
The role of brain-derived neurotrophic factor in transient forebrain ischemia in the rat brain. Neurosurgery (1994) 0.89
A novel RING-H2 motif protein downregulated by axotomy: its characteristic localization at the postsynaptic density of axosomatic synapse. J Neurosci (1995) 0.88
Severe developmental delay and epilepsy in a Japanese patient with severe congenital neutropenia due to HAX1 deficiency. Haematologica (2007) 0.87
Structural comparison of phospholipase-A2-binding regions in phospholipase-A2 receptors from various mammals. Eur J Biochem (1994) 0.86
The yeast exchange assay, a new complementary method to screen for Dbl-like protein specificity: identification of a novel RhoA exchange factor. FEBS Lett (2000) 0.84
Toluene induces rapid and reversible rise of hippocampal glutamate and taurine neurotransmitter levels in mice. Toxicol Lett (2006) 0.84
Direct DNA sequencing of PCR products. Curr Protoc Mol Biol (2001) 0.84
One-sided anchored polymerase chain reaction for amplification and sequencing of complementary DNA. Methods Enzymol (1993) 0.83
Cross-linking study on skeletal muscle actin: properties of suberimidate-treated actin. J Biochem (1982) 0.83
Pancreatic-type phospholipase A2 induces group II phospholipase A2 expression and prostaglandin biosynthesis in rat mesangial cells. J Biol Chem (1994) 0.83
Severe primary antibody deficiency due to a novel mutation of mu heavy chain. J Investig Allergol Clin Immunol (2012) 0.82
Cellular and subcellular localization of a newly identified member of the protein 4.1 family, brain 4.1, in the cerebellum of adult and postnatally developing rats. Brain Res Dev Brain Res (1999) 0.82
Studies on the regulation of one-carbon metabolism. The effects of folate concentration in the growth medium on the activity of three folate-dependent enzymes in Lactobacillus casei. J Biol Chem (1969) 0.82
Brain-derived neurotrophic factor pretreatment exerts a partially protective effect against glutamate-induced neurotoxicity in cultured rat cortical neurons. Neurosci Lett (1993) 0.81
A case of intracystic carcinoma of the breast: the importance of measuring carcinoembryonic antigen in aspirated cystic fluid. Breast Cancer Res Treat (1993) 0.80
Characterization of long cDNA clones from human adult spleen. DNA Res (2000) 0.79
A new solid-phase chemical DNA sequencing method which uses streptavidin-coated magnetic beads. DNA Res (1995) 0.79
Analysis of brain proteins in Alzheimer's disease using high-resolution two-dimensional gel electrophoresis. J Neurol Sci (1999) 0.79
cDNA amplification using one-sided (anchored) PCR. Curr Protoc Mol Biol (2001) 0.78
Sequence-dependent separation of DNA fragments by capillary electrophoresis in the presence of SYBR Green I. Biotechniques (1997) 0.78
Sequence-dependent DNA separation by anion-exchange high-performance liquid chromatography. Anal Biochem (1996) 0.78
Hyper IgM syndrome and complement Clq deficiency in an individual with systemic lupus erythematosus-like disease. Clin Exp Rheumatol (2010) 0.77
Identification of novel transcribed sequences on human chromosome 22 by expressed sequence tag mapping. DNA Res (2001) 0.77
Disorganization of microfilaments is accompanied by downregulation of alpha-smooth muscle actin isoform mRNA level in cultured vascular smooth muscle cells. J Biochem (1992) 0.77
Structural characterization of pancreatic group I phospholipase A2 receptor. Adv Prostaglandin Thromboxane Leukot Res (1995) 0.77
Pancreatic-type phospholipase A2 activates prostaglandin E2 production in rat mesangial cells by receptor binding reaction. J Biochem (1995) 0.77
Detection of spurious interruptions of protein-coding regions in cloned cDNA sequences by GeneMark analysis. Genome Res (2000) 0.77
Purification and characterization of recombinant murine immune interferon. FEBS Lett (1986) 0.77
Systemic effects of transdermal testosterone for the treatment of microphallus in children. Pediatr Int (2001) 0.77
Ataxia-telangiectasia in a patient presenting with hyper-immunoglobulin M syndrome. J Investig Allergol Clin Immunol (2010) 0.76
Activation of group II phospholipase A2 gene via two distinct mechanisms in rat vascular smooth muscle cells. Adv Prostaglandin Thromboxane Leukot Res (1991) 0.75
[A nested deletion method for cosmid DNA using the bacteriophage T3 in vitro packaging system]. Tanpakushitsu Kakusan Koso (1997) 0.75
Chronic granulomatous disease: two decades of experience from a tertiary care centre in North West India. J Clin Immunol (2013) 0.75
A new simplified method for preparation of a synthetic phage antibody with practically acceptable detection sensitivity on immunoblots. Hum Antibodies (2001) 0.75
Cross-linking study on skeletal muscle actin: interaction of suberimidate-treated actin with deoxyribonuclease I. J Biochem (1983) 0.75
A novel method for generating nested deletions using the in vitro bacteriophage T3 DNA packaging system. DNA Res (1994) 0.75
A method for removing copper from charcoal of waste wood using an electrical current. Bull Environ Contam Toxicol (2007) 0.75
An improved cosmid vector for the nested deletion method using the bacteriophage T3 DNA packaging system. DNA Res (1996) 0.75
Novel mutation of IL2RG gene in a Korean boy with X-linked severe combined immunodeficiency. J Investig Allergol Clin Immunol (2013) 0.75
Successful treatment of systemic cytomegalovirus infection in severe combined immunodeficiency using allogeneic bone marrow transplantation followed by adoptive immunotherapy. J Investig Allergol Clin Immunol (2014) 0.75
Receptor-binding capability of pancreatic phospholipase A2 is separable from its enzymatic activity. FEBS Lett (1993) 0.75
Anomalous behavior of human leukocyte interferon subtypes on polyacrylamide gel electrophoresis in the presence of dodecyl sulfate. FEBS Lett (1987) 0.75
XPS and NEXAFS studies of VUV/O₃-treated aromatic polyurea and its application to microchip electrophoresis. IET Nanobiotechnol (2011) 0.75
Analysis of Mutations in the IL2RG Gene in 2 Asian Infants With X-linked Severe Combined Immunodeficiency. J Investig Allergol Clin Immunol (2015) 0.75